1. Home
  2. UVV vs CSTL Comparison

UVV vs CSTL Comparison

Compare UVV & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Corporation

UVV

Universal Corporation

HOLD

Current Price

$54.14

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$40.31

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UVV
CSTL
Founded
1886
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
UVV
CSTL
Price
$54.14
$40.31
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$46.00
AVG Volume (30 Days)
176.2K
331.6K
Earning Date
02-09-2026
02-26-2026
Dividend Yield
6.04%
N/A
EPS Growth
N/A
N/A
EPS
4.44
N/A
Revenue
$2,987,411,000.00
$343,530,000.00
Revenue This Year
$3.21
$2.54
Revenue Next Year
$1.02
N/A
P/E Ratio
$12.24
N/A
Revenue Growth
3.01
10.15
52 Week Low
$49.96
$14.59
52 Week High
$67.33
$42.18

Technical Indicators

Market Signals
Indicator
UVV
CSTL
Relative Strength Index (RSI) 55.01 57.91
Support Level $53.53 $38.73
Resistance Level $56.02 $41.60
Average True Range (ATR) 0.89 1.58
MACD 0.16 -0.12
Stochastic Oscillator 59.57 62.75

Price Performance

Historical Comparison
UVV
CSTL

About UVV Universal Corporation

Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: